SAMHSA [3/27] | In a letter to clinicians, SAMHSA wrote that xylazine is an emerging public health threat and noted that routine toxicology tests do not test for the substance. Cont.
Ann Tucker
top of page
Search
Recent Posts
See AllBloomberg Government [9/09] - The Biden administration is poised to issue a final rule toughening mandates for employer-sponsored health...
Forbes [7/09] - Purdue Pharma went back to court this week after the Supreme Court thwarted the OxyContin maker’s...
bottom of page
Comments